DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Chester, PA

6 verified pulmonary disease doctors in Chester.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Pennsylvania State Board of Medicine

Dr. Pierre Frederique, MD

Pulmonary Disease

20 yrs NPPES
NPI 1235243502
1 MEDICAL CENTER BLVD, PROF. BLDG. 2 SUITE 422, Chester, PA 19013(610) 619-7460
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $983.18 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$983.18

Total received

41

Transactions

10

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$261.92
Genzyme Corporation$239.27
GlaxoSmithKline, LLC.$209.02
Insmed, Inc.$97.46
AbbVie Inc.$51.42
Regeneron Healthcare Solutions, Inc.$34.35

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 79th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Pierre Frederique do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Gary Wendell, MD

Pulmonary Disease

20 yrs NPPES
NPI 1497868848
1 MEDICAL CENTER BLVD, PROF. BLDG. 2 SUITE 422, Chester, PA 19013(610) 619-7460
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $566.35 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$566.35

Total received

23

Transactions

9

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$191.44
GlaxoSmithKline, LLC.$83.55
Mylan Specialty L.P.$66.69
Genzyme Corporation$48.56
Grifols USA, LLC$44.40
Regeneron Healthcare Solutions, Inc.$34.93

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 74th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Gary Wendell do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Asad Khan, MD

Pulmonary Disease

20 yrs NPPES
NPI 1134233372
1 MEDICAL CENTER BLVD, PROF. BLDG. 2, Chester, PA 19013(610) 619-7460
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,587 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,587

Total received

70

Transactions

18

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$266.31
GlaxoSmithKline, LLC.$233.81
Genzyme Corporation$229.26
Harmony Biosciences LLC$177.65
Amgen Inc.$109.44
Insmed, Inc.$95.23

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 84th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Asad Khan do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Leonard Berkowitz, MD

Pulmonary Disease

20 yrs NPPES
NPI 1558477422
1 MEDICAL CENTER BLVD, PROF. BLDG. 2 SUITE 422, Chester, PA 19013(610) 619-7460
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Kuo Tchong, MD

Pulmonary Disease

20 yrs NPPES
NPI 1811008287
1 MEDICAL CENTER BLVD, PROF. BLDG. 2 SUITE 422, Chester, PA 19013(610) 619-7460
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Wei Bin, MD

Pulmonary Disease

18 yrs NPPES
NPI 1619135043
1 MEDICAL CENTER BLVD, PROF. BLDG. 2 SUITE 422, Chester, PA 19013(610) 619-7460
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,405 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,405

Total received

63

Transactions

16

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$343.80
Harmony Biosciences LLC$212.31
Genzyme Corporation$198.55
GlaxoSmithKline, LLC.$167.62
Insmed, Inc.$97.50
Axsome Therapeutics, Inc.$64.06

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 83th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Wei Bin do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Chester, PA — Verified | DoctorsProof | DoctorsProof